New blood test could speed up infection diagnosis
NCT ID NCT05305534
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a new diagnostic device, the QIAstat-Dx panels, to see how well it identifies bacteria in blood samples from people with suspected bloodstream infections. Researchers compared the test results to standard methods using over 2000 samples. The goal is to provide faster and more accurate results to guide treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QIAstat-Dx® BCID GN and GPF Plus AMR Panels (diagnostic device)
- What this could lead to
- If successful, this could provide a faster, more accurate way to identify bacteria causing bloodstream infections, helping doctors choose the right antibiotics sooner.
- What could go wrong
- This is a completed diagnostic accuracy study, not a treatment trial. The test may not be widely adopted or may have limitations in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QIAGEN
Manchester, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.